Capital Fund Management (CFM)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Capital Fund Management (CFM)’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,700	Closed	-$270K	–	1865
2017 Q1	$270K	Sell	2,700 -3,828	-59%	-$409K	﹤0.01%	1323
2016 Q4	$702K	Buy	6,528 +827	+15%	+$96.7K	0.01%	1140
2016 Q3	$710K	Buy	5,701 +3,179	+126%	+$375K	0.01%	1075
2016 Q2	$268K	Buy	+2,522	New	+$293K	﹤0.01%	1356

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital Fund Management (CFM)'s CBPO Position: Q2 2017 in Review

Capital Fund Management (CFM) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 2,700 shares — an estimated $270K sold.

Capital Fund Management (CFM) first reported a position in CBPO in Q2 2016 and held it in 4 quarters. The position peaked at $710K in Q3 2016. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Capital Fund Management (CFM) reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Capital Fund Management (CFM) sold 2,700 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $270K.
Capital Fund Management (CFM) first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 4 quarters.
Capital Fund Management (CFM)'s China Biologic Products Holdings, Inc. position peaked at $710K in Q3 2016.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2017, filed 10 Aug 2017.